Literature DB >> 33555353

Significant Improvement After Surgery for a Symptomatic Osteoblastoma in a Patient with Camurati-Engelmann Disease: Case Report and Literature Review.

Hirotaka Yonezawa1, Katsuhiro Hayashi1, Norio Yamamoto2, Akihiko Takeuchi1, Kaoru Tada1, Shinji Miwa1, Kentaro Igarashi1, Hiroaki Kimura1, Yu Aoki1, Sei Morinaga1, Yoshihiro Araki1, Yohei Asano1, Keisuke Sakurakichi3, Hiroko Ikeda4, Takayuki Nojima1,4, Hiroyuki Tsuchiya1.   

Abstract

Camurati-Engelmann disease (CED) is a rare, progressive diaphyseal dysplasia characterized as diaphyseal hyperostosis and sclerosis of the long bones. Corticosteroids, bisphosphonates, and losartan have been reported to be effective systemic medications used to reduce CED symptoms. There are no reports of osteoblastoma in patients with CED, and osteoblastoma in the distal radius is rare. We present a patient diagnosed with CED, based on radiological and histological examinations, at 11 years old. At 22 years old, she experienced severe pain in her right forearm and was treated with bisphosphonate, losartan, and prednisolone; however, the pain continued. An expansive and sclerotic lesion at the distal radius was observed on radiography. A follow-up plain radiograph indicated that the lesion was growing. Fluorodeoxyglucose positron emission tomography revealed solitary, intense radiotracer uptake, and a biopsy and surgical resection were performed due to suspected malignancy. Pathologic analysis showed anastomosing bony trabeculae rimmed by osteoblasts observed in a loose fibrovascular stroma. The lesion was diagnosed as an osteoblastoma. Following bone excision and artificial bone grafting, the patient's severe pain almost completely disappeared. At final follow-up, no evidence of osteoblastoma recurrence was noted. To our knowledge, this is the first case report of osteoblastoma arising in a patient with CED. Bone excision and artificial bone grafting may be a treatment option for local symptomatic osteoblastoma in patients with CED.

Entities:  

Keywords:  Bisphosphonate; Camurati–Engelmann disease; Excision; Hyperostosis; Osteoblastoma; Progressive diaphyseal dysplasia

Mesh:

Year:  2021        PMID: 33555353     DOI: 10.1007/s00223-021-00813-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  13 in total

1.  Camurati-Engelmann disease: failure of response to bisphosphonates: report of two cases.

Authors:  Glaucio R W Castro; Simone Appenzeller; João Francisco Marques-Neto; Manoel B Bértolo; Adil M Samara; Ibsen Coimbra
Journal:  Clin Rheumatol       Date:  2005-01-20       Impact factor: 2.980

2.  A significant improvement in lower limb pain after treatment with alendronate in two cases of Camurati-Engelmann disease.

Authors:  Kousuke Iba; Junichi Takada; Hotaka Kamasaki; Takashi Oda; Naoko Hatakeyama; Takuro Wada; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

3.  Case for Diagnosis.

Authors:  E A Cockayne
Journal:  Proc R Soc Med       Date:  1920

4.  Camurati-Engelmann disease type II: progressive diaphyseal dysplasia with striations of the bones.

Authors:  Gen Nishimura; Hitoshi Nishimura; Yoko Tanaka; Yoshio Makita; Shiro Ikegawa; Mohsen Ghadami; Akira Kinoshita; Norio Niikawa
Journal:  Am J Med Genet       Date:  2002-01-01

5.  Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease.

Authors:  A Kinoshita; T Saito; H Tomita; Y Makita; K Yoshida; M Ghadami; K Yamada; S Kondo; S Ikegawa; G Nishimura; Y Fukushima; T Nakagomi; H Saito; T Sugimoto; M Kamegaya; K Hisa; J C Murray; N Taniguchi; N Niikawa; K Yoshiura
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

Review 6.  Skull base manifestations of Camurati-Engelmann disease.

Authors:  Matthew L Carlson; Charles W Beatty; Brian A Neff; Michael J Link; Colin L W Driscoll
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-06

Review 7.  Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.

Authors:  Thomas C Kwee; John M H de Klerk; Maarten Nix; Ben G F Heggelman; Stefan V Dubois; Hugo J A Adams
Journal:  Semin Nucl Med       Date:  2017-04-12       Impact factor: 4.446

Review 8.  Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.

Authors:  K Janssens; F Vanhoenacker; M Bonduelle; L Verbruggen; L Van Maldergem; S Ralston; N Guañabens; N Migone; S Wientroub; M T Divizia; C Bergmann; C Bennett; S Simsek; S Melançon; T Cundy; W Van Hul
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

Review 9.  Camurati-Engelmann Disease.

Authors:  Wim Van Hul; Eveline Boudin; Filip M Vanhoenacker; Geert Mortier
Journal:  Calcif Tissue Int       Date:  2019-02-05       Impact factor: 4.333

10.  Osteoblastoma: a 30-year study of 99 cases.

Authors:  Micah Berry; Henry Mankin; Mark Gebhardt; Andrew Rosenberg; Francis Hornicek
Journal:  J Surg Oncol       Date:  2008-09-01       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.